NURO logo

NeuroMetrix (NURO)

Profile

Full Name

NeuroMetrix, Inc.

Ticker Symbol

NURO

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Devices

Country

United States

IPO

July 22, 2004

Indexes

Not included

Website

http://www.neurometrix.com

Employees

26

Key Details

Price

$4.41(0.00%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$3.03M(-48.61% YoY)

Annual EPS

-$3.96(+36.84% YoY)

PE ratio

-

Next earnings date

May 15, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$4.41
NURO price is $4.41

30-Day Relative Volume

0.00
NURO 30-day relative volume is 0.00

Price Performance

Price Most recent change

0%
NURO {parameterFullLabel} has remained unchanged on Apr 11, 2025

Price YTD change

+11.08%
NURO price is up +11.08% since January 1st

Price 1-year change

+14.55%
NURO price is up +14.55% year-on-year

Price 3-year change

-86.75%
NURO price is down -86.75% over the past 3 years

Price Range

Price All-time high

$3796070.50
NURO price is currently -100.00% below its historical high of $3796070.50

Price 3-year low

$2.66
NURO price is currently +65.79% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$9.08M
NURO market capitalization is $9.08 million

Market cap 3-year change

-68.84%
NURO market capitalization is down -68.84% over the past 3 years

Market cap All-time high

$372.23M
NURO market capitalization is currently -97.56% below its historical high of $372.23 million

Market cap sector rank

18.82%
NURO market capitalization is higher than 18.82% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+3.66%
NURO shares outstanding is up +3.66% year-on-year

Shares Outstanding 3-Year Change

+135.18%
NURO shares outstanding is up +135.18% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

-0.04
NURO beta is -0.04

200-day SMA

$4.01
NURO price is currently +9.99% above its 200-day simple moving average

50-day SMA

$4.40
NURO price is currently +0.28% above its 50-day simple moving average

RSI

50.67
NURO 14-day relative strength index is 50.67

Volume

0.00
NURO 30-day relative volume is 0.00

ATR

$0.07
NURO average true range is $0.07

10-day Historical Volatility

13.82%
NURO 10-day historical volatility is 13.82%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$3.03M
NURO annual revenue is $3.03 million

Revenue Analysts estimate

-
NURO annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-48.61%
NURO annual revenue is down -48.61% year-on-year

Revenue Sector rank

18.14%
NURO annual revenue is higher than 18.14% of companies in Healthcare sector

EPS

EPS

-$3.96
NURO annual earnings per share is -$3.96

EPS Analysts estimate

-
NURO annual earnings per share consensus analysts' forecast is unknown

EPS 1-year change

+36.84%
NURO annual earnings per share is up +36.84% year-on-year

EPS Sector rank

22.96%
NURO annual earnings per share is higher than 22.96% of companies in Healthcare sector

Profit

Gross profit

$1.68M
NURO annual gross profit is $1.68 million

Gross margin

55.38%
NURO annual gross profit margin is 55.38%

Operating profit

-$8.78M
NURO annual operating income is -$8.78 million

Operating margin

-289.57%
NURO annual operating profit margin is -289.57%

Net income

-$7.81M
NURO annual net profit is -$7.81 million

Net margin

-257.38%
NURO annual net profit margin is -257.38%

Expenses

Total expenses

$11.81M
NURO annual total expenses is $11.81 million

Operating expenses

$10.46M
NURO annual total operating expenses is $10.46 million

Cost of goods sold

$1.35M
NURO annual cost of goods sold is $1.35 million

Selling, general & administrative expenses

$8.67M
NURO annual SGA is $8.67 million

Depreciation and amortization

$233.00K
NURO annual depreciation & amortization is $233.00 thousand

Interest expense

-
NURO annual interest expense value is unknown

Income tax

-
NURO annual income tax value is unknown

EBIT & EBITDA

EBIT

-$8.78M
NURO annual earnings before interest & taxes is -$8.78 million

EBITDA

-$8.55M
NURO annual EBITDA is -$8.55 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$15.32M
NURO annual total assets is $15.32 million

Non current assets

$310.60K
NURO annual long term assets is $310.60 thousand

Current assets

$15.01M
NURO annual total current assets is $15.01 million

Cash and cash equivalents

$1.43M
NURO annual cash & cash equivalents is $1.43 million

Accounts receivable

$192.90K
NURO annual accounts receivable is $192.90 thousand

Inventory

$1.35M
NURO annual inventory is $1.35 million

Liabilities

Total liabilities

$1.01M
NURO annual total liabilities is $1.01 million

Long term liabilities

$0.00
NURO annual total long term liabilities is $0.00

Current liabilities

$1.01M
NURO annual total current liabilities is $1.01 million

Accounts payable

$363.30K
NURO annual accounts payable is $363.30 thousand

Debt

Total debt

$107.40K
NURO annual total debt is $107.40 thousand

Total debt 1-year change

-55.42%
NURO annual total debt is down -55.42% year-on-year

Long term debt

$0.00
NURO annual long term debt is $0.00

Short term debt

$107.40K
NURO annual short term debt is $107.40 thousand

Equity & Capital

Shareholders equity

$14.31M
NURO annual stockholders equity is $14.31 million

Book value

$14.31M
NURO annual book value is $14.31 million

Retained earnings

-$217.92M
NURO annual retained earnings is -$217.92 million

Working capital

$14.00M
NURO annual working capital is $14.00 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$7.13M
NURO annual cash flow from operations is -$7.13 million

Cash from operations 1-year change

-17.15%
NURO annual cash flow from operations is down -17.15% year-on-year

Cash from investing

$5.35M
NURO annual cash flow from investing activities is $5.35 million

Cash from investing 1-year change

+362.46%
NURO annual cash flow from investing activities is up +362.46% year-on-year

Cash from financing

$1.48M
NURO annual cash flow from financing activities is $1.48 million

Cash from financing 1-year change

-36.51%
NURO annual cash flow from financing activities is down -36.51% year-on-year

CAPEX

CAPEX

-
NURO annual capital expenditures value is unknown

CAPEX 1-year change

-
NURO annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$7.13M
NURO annual free cash flow is -$7.13 million

Free cash flow 1-year change

-13.72%
NURO annual free cash flow is down -13.72% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

55.38%
NURO annual gross profit margin is 55.38%

Operating margin

-289.57%
NURO annual operating profit margin is -289.57%

Net margin

-257.38%
NURO annual net profit margin is -257.38%

ROA & ROE

ROA

-42.48%
NURO annual return on assets is -42.48%

ROE

-45.38%
NURO annual return on equity is -45.38%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
NURO price to earnings ratio value is unknown

PE ratio Sector rank

-
NURO price to earnings ratio is unknown

PB Ratio

PB ratio

0.63
NURO price to book ratio is 0.63

PB ratio Sector rank

34.87%
NURO price to book ratio is higher than 34.87% of companies in Healthcare sector

PS Ratio

PS ratio

3.00
NURO price to sales ratio is 3.00

PS ratio Sector rank

52.31%
NURO price to sales ratio is higher than 52.31% of companies in Healthcare sector

Enterprise value

Enterprise value

$7.76M
NURO enterprise value is $7.76 million

Enterprise value Sector rank

23.25%
NURO enterprise value is higher than 23.25% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.91
NURO EV/EBITDA is -0.91

EV/EBITDA Sector rank

43.4%
NURO EV/EBITDA is higher than 43.4% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

14.83
NURO annual current ratio is 14.83

Quick ratio

13.50
NURO annual quick ratio is 13.50

Leverage

Debt to equity

0.00
NURO annual debt to equity ratio is 0.00

Interest coverage ratio

-
NURO annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

2
NURO piotroski f-score is 2

Altman Z-Score

-15.12
NURO altman z-score is -15.12

Analyst ratings

Recent major analysts updates

Nov 25, 20 Rodman & Renshaw
Buy
Jun 28, 16 Rodman & Renshaw
Buy

Institutional Ownership

Similar stocks

BCDA logo
BioCardia (BCDA)
EKSO logo
Ekso Bionics Holdings (EKSO)
HOOK logo
HOOKIPA Pharma (HOOK)
FLGC logo
Flora Growth (FLGC)
POAI logo
Predictive Oncology (POAI)
Turnstone Biologics (TSBX)
COSCIENS Biopharma (CSCI)
SNSE logo
Sensei Biotherapeutics (SNSE)
Neuphoria Therapeutics (NEUP)
  • What is the ticker symbol for NeuroMetrix?
  • Does NeuroMetrix pay dividends?
  • What sector is NeuroMetrix in?
  • What industry is NeuroMetrix in?
  • What country is NeuroMetrix based in?
  • When did NeuroMetrix go public?
  • Is NeuroMetrix in the S&P 500?
  • Is NeuroMetrix in the NASDAQ 100?
  • Is NeuroMetrix in the Dow Jones?
  • When was NeuroMetrix's last earnings report?
  • When does NeuroMetrix report earnings?
  • Should I buy NeuroMetrix stock now?

What is the ticker symbol for NeuroMetrix?

The ticker symbol for NeuroMetrix is NASDAQ:NURO

Does NeuroMetrix pay dividends?

No, NeuroMetrix does not pay dividends

What sector is NeuroMetrix in?

NeuroMetrix is in the Healthcare sector

What industry is NeuroMetrix in?

NeuroMetrix is in the Medical Devices industry

What country is NeuroMetrix based in?

NeuroMetrix is headquartered in United States

When did NeuroMetrix go public?

NeuroMetrix's initial public offering (IPO) was on July 22, 2004

Is NeuroMetrix in the S&P 500?

No, NeuroMetrix is not included in the S&P 500 index

Is NeuroMetrix in the NASDAQ 100?

No, NeuroMetrix is not included in the NASDAQ 100 index

Is NeuroMetrix in the Dow Jones?

No, NeuroMetrix is not included in the Dow Jones index

When was NeuroMetrix's last earnings report?

NeuroMetrix's most recent earnings report was on Nov 5, 2024

When does NeuroMetrix report earnings?

The next expected earnings date for NeuroMetrix is May 15, 2025

Should I buy NeuroMetrix stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page